spacer
home > pmps > winter 2019 > a new phase of hope
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A New Phase of Hope

The global pharmaceutical industry has entered an exciting new era of drug development, bringing new hope to patients around the world. Close to 40% of all medicines in pipeline development are estimated to be biologic in nature.

The world’s top-selling commercial biologic medicines cover a broad range of diseases (including autoimmune challenges such as various forms of arthritis and psoriasis, Crohn’s disease, ankylosing spondylitis, ulcerative colitis, and other conditions such as multiple sclerosis and macular degeneration), bringing hope to many long-suffering patients.

Biologic medicines have also transformed treatment and personal care for a significant portion of the diabetes patient population. Furthermore, biologics have provided breakthrough therapies in the advanced treatment for various forms of cancer, where more than 70 new therapies have entered the market within the past five years, many of which are biologic in nature.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Justin Schroeder is Senior Executive Director of Global Marketing and Design at PCI Pharma Services, with over 20 years’ experience in outsourced pharma services in various roles, including engineering, project management, marketing, and development.
spacer
Justin Schroeder
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PHARM Connect 2019

Life science and business are going to meet at PHARM Connect on the 12-13 of March 2019 in Budapest, Hungary to continue the tradition of providing high calibre, customised professional partnering opportunities for pharma and biotech professionals from Central & Eastern European and beyond and deliver the crucial information they need to excel in their work. The influential annual gathering brings together over 400 global and regional decision-makers, top scientists, industry executives and business development leaders for the ninth time to identify new business opportunities, technologies, state-of-the-art formulation development strategies and to foster exchange of ideas on the role of the sector.
More info >>

White Papers

Bringing more control to temperature-sensitive logistics

UPS Supply Chain Solutions

By 2016, world sales of cold-chain drugs and biologics such as vaccines and blood plasma products will near $240 billion1. The increase has led to a surge in discussion about how to protect these products throughout the transportation logistics cycle. Industry experts are recommending that the term “cold chain” be eliminated from rules, guidance and best-practice documents. “Cold chain” now includes a broader spectrum of temperature ranges, such as controlled room temperature (CRT). This white paper focuses on the initial steps required to establish a temperature-sensitive supply chain.
More info >>

 
Industry Events

LogiPharma 2019

9-11 April 2019, Montreux Music & Convention Centre

LogiPharma is the world’s leading pharma supply chain event. With over 950+ pharma supply chain leaders exclusively meeting in one place at one time, LogiPharma is THE meeting place to benchmark your business with the best pharma companies and shape the future of your industry.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement